C¹⁷ Council is seeking nominations for the following positions:

C¹⁷ Council Executive Committee Vice-Chair (open)
C¹⁷ Council Executive Committee Treasurer (Director)
C¹⁷ DVL Committee Co-Chair (non-MD)
C¹⁷ Human Resources Co-Chair (non-MD)
C¹⁷ Hematology Task Force (open)

Nominations may be submitted by an individual interested in the position, or by a member of C¹⁷. Submit nominations to Kathy Brodeur-Robb, Executive Director, C¹⁷ Council, by email at kathy.brodeur-robb@c17.ca.

If not a self-nomination, the nominee must indicate that they accept the nomination. The nomination should provide a brief description of their qualifications, vision and goals for the position, and provide a copy of their CV. Nominations will be accepted until the deadline listed. The position will be voted on by the C¹⁷ Council.

Position: VICE-CHAIR, C¹⁷ Council Executive
Term: 3 years
Nomination deadline: 1 March 2024

If appointed, the Vice-Chair shall attend meetings of the C¹⁷ executive, Board of Directors, and annual full member meetings and participate in electronic discussion and voting related to the business of C¹⁷Council. The Vice-Chair shall Chair meetings in the absence of the Chair or when the Chair is in conflict of interest. The Vice-Chair shall assist with governance and leadership of C¹⁷ Council.

Requirements: The Vice-Chair need not be a director or an MD. However, if the successful candidate is not a program director then they will have voting rights at the executive, but will not have a vote as a program director at the Board of Directors.

Position: TREASURER, C¹⁷ Council Executive
Term: 3 years
Nomination deadline: 1 June 2024

If appointed, the Treasurer shall attend meetings of the C¹⁷ executive, Board of Directors, and annual full member meetings and participate in electronic discussion and voting related to the business of C¹⁷ Council. The Treasurer shall work with the Executive Director to develop the annual C¹⁷ budget for approval, be responsible for oversight of the annual financial audit (contracted out to a professional accounting firm), act as one of the signing authorities for C¹⁷ Council for agreements, bank accounts and cheques. The Treasurer shall be responsible for financial planning and oversight for C¹⁷ Council.

Requirements: The Treasurer must be a C¹⁷ Council Director.

Position: CO-CHAIR (non-MD), Developmental Therapeutics Committee (DVL), C¹⁷ Council
Term: 3 years
Nomination deadline: 1 March 2024

If appointed, the DVL Co-Chair shall attend meetings of the C¹⁷DVL Committee and annual C¹⁷ Council full member meetings and participate in electronic discussion and voting related to the business of C¹⁷ DVL Committee. The Co-Chair shall assist the other Co-Chair providing direction and leadership to the C¹⁷ DVL committee, chair meetings in the absence of the other Chair or when the Chair is in conflict of interest. The Co-Chair shall assist with governance and leadership of C¹⁷ DVL Committee, report on activities and budget to C¹⁷ Council, and work closely with the C¹⁷ Council operations office on clinical trials.

Requirements: The Co-Chair (non-MD) position is open to any member of C¹⁷ who is not an MD. Knowledge of clinical trials, regulations and policy in Canada is required.

Position: CO-CHAIR (non-MD), Human Resources Committee (HR), C¹⁷ Council
Term: 3 years
Nomination deadline: 1 March 2024

If appointed, the HR Co-Chair shall attend meetings of the C¹⁷ HR Committee and annual C¹⁷Council full member meetings and participate in electronic discussion and voting related to the business of C¹⁷ HR Committee. The HR committee is responsible for the annual HR surveys developed and sent out to programs, and for pursuing initiatives related to scope of work, workload issues, program staffing, etc. The Co-Chair shall assist the other Co-Chair providing direction and leadership to the C¹⁷ HR committee, chair meetings in the absence of the other Chair or when the Chair is in conflict of interest. The Co-Chair shall assist with governance and leadership of C¹⁷ HR Committee, report on activities and budget to C¹⁷ Council, and work closely with the C¹⁷ Council operations office on HR surveys.

Requirements: The Co-Chair (non-MD) position is open to any member of C¹⁷ who is not an MD. Knowledge of surveys, workforce and workload issue, and human resources and staffing is relevant.

Position: CO-CHAIR, Hematology Task Force (TF), C¹⁷ Council
Term: 3 years
Nomination deadline: CO-CHAIR, Hematology Task Force (TF), C¹⁷ Council

If appointed, the Hematology Co-Chair shall attend meetings of the C¹⁷ Hematology TF and annual C¹⁷ Council full member meetings and participate in electronic discussion and voting related to the business of C¹⁷ Hematology TF. The Hematology TF is responsible for understanding, promoting and developing the hematology the annual HR surveys developed and sent out to programs, and for pursuing initiatives related to scope of work, workload issues, program staffing, etc. The Co-Chair shall assist the other Co-Chair(s) providing direction and leadership to the C¹⁷ Hematology TF, chair meetings in the absence of the other Chair(s) or when the Chair is in conflict of interest. The Co-Chair shall assist with governance and leadership of C¹⁷ Hematology TF, report on activities and budget to C¹⁷ Council, and work closely with the C¹⁷Council operations office on hematology issues and the C¹⁷ HR committee on HR surveys.

Requirements: More than one Co-Chair (MD or non-MD) may be selected. The position is open to any member of C¹⁷ who is an MD or from other health professions. Knowledge of hematology as well as surveys, workforce and workload issue is relevant.

January 25, 2024

in Job Postings

JOB POSTING: Pediatric Oncologist-Hematologist, CancerCare Manitoba

PEDIATRIC ONCOLOGIST-HEMATOLOGIST WITH INTEREST IN PEDIATRIC NEURO-ONCOLOGY

The Department of Pediatric Oncology-Hematology – BMT at CancerCare Manitoba and the Department of Pediatrics and Child Health, Max Rady College of Medicine, University of Manitoba, invite applications for the position of Full Time Pediatric Hematologist-Oncologist. This position includes an appointment with the University of Manitoba as a Geographical Full-Time academic physician, with rank of Assistant, Associate or full Professor based upon qualifications. While clinical skills in all areas of Pediatric Hematology-Oncology are required (including Pediatric Oncology, Hematology, and BMT), the successful candidate should have an area of specific training and interest in Pediatric Neuro-Oncology and would join another physician in our group with Pediatric Neuro-Oncology focus. The position includes clinical care for all infants, children, and adolescents with pediatric brain tumours, including participation in Brain Tumour Rounds, managing Neuro-Oncology patients on targeted therapies, and continuing the development of the Pediatric Neuro-Oncology program at CancerCare Manitoba and the Winnipeg Children’ s Hospital. The position would include opportunities for being a site principal investigator for multi-institution trials (both clinical / non-clinical trials) and future development of investigator-initiated trials. Although the focus will be on Pediatric Neuro-Oncology, all attending physicians in our group still participate in general Pediatric Hematology and Oncology service, leaving opportunities to continue to manage the spectrum of disorders within the specialty. Coverage of Blood and Marrow Transplant patients occurs only on the weekends with appropriate subspecialist back up as required. Clinical service and on-call responsibilities are proportionately shared amongst all attending physician members of the Department of Pediatric Oncology Hematology-BMT.

The Department of Pediatric Oncology and Hematology, CancerCare Manitoba consists of eight faculty members with active clinical and research programs in pediatric oncology, neuro-oncology, blood and marrow transplant, hematology, hemostasis and thrombosis. It is the sole Pediatric Oncology-Hematology Program seeing patients from across the Province of Manitoba, Northwestern Ontario and parts of Nunavut. Our program is an active contributor to Children’ s Oncology Group and other collaborative clinical group trials, has a blood and marrow transplant program with FACT accreditation, a Royal College accredited subspecialty training program in Pediatric Hematology-Oncology and is well supported by all pediatric subspecialties including experienced pediatric neurosurgeons, pediatric radiologists, and pediatric neuropathologists.

For more information to apply, visit: Pediatric Oncologist-Hematologist (wrha.mb.ca)

January 25, 2024

in C17 Education Committee, education & training, Funding Opportunities, Scholarships

Norma Auger Education Fund – application deadline: February 1, 2024

The goal of the of the Norma Auger Education Fund is to support health professionals involved in pediatric Oncology/Hematology/BMT across Canada advance their knowledge, skills and experience and to promote presentations and knowledge translation by these health professionals.

This is an annual scholarship offered by the C17 Education Committee with funding from the Childhood Cancer Canada Foundation. Application deadlines are: February 1st, May 1st, August 1st and November 1st annually.

To be eligible, you must be a non-MD Pediatric Oncology/Hematology/BMT health care professional working in Canada.

To find out more information, and to apply, visit the C17 website: https://c17.ca/committees/education

January 15, 2024

in C17 Council

Join Forces for Life: C17 Council and Canadian Blood Services!

C17 Council has partnered with Canadian Blood Services to help make a difference for patients in Canada.

Join our team and help save lives. Join today at https://myaccount.blood.ca/en/join-team/C17C0115147

December 12, 2023

in ACCESS, survey

Needs Assessment – ACCESS Education and Training Matrix

Dear pediatric oncology community,

We would like to invite you to complete a survey on behalf of Advancing Childhood Cancer Experience, Science and Survivorship (ACCESS) exploring the research and career development training needs of the Canadian pediatric oncology community.

One of the priorities of the Education and Training Theme is to create research training and career development educational materials/curriculum. As we plan this curriculum, we have developed a survey to help us determine the educational needs of Canadian pediatric clinicians, research staff, researchers, and trainees.

This survey is open to:

Pediatric oncology clinicians/research staff (e.g nursing, pharmacy, CRAs, physicians, social work, psychologists amongst others) including trainees
Pediatric researchers including trainees

The survey should take 5-10 minutes to complete and is anonymous. It has been reviewed by the BC Children’s Hospital Research Ethics Board (REB) and granted REB exemption.

Those who complete the survey will be entered in a draw to win one of several Amazon Canada gift cards!

The survey can be found here:

Deadline for completion: January 20, 2024

If you have any questions, please contact jenna.craig@sickkids.ca

Thank you,
Chiquita, Dawn, Laura, and Meera
Education and Training ACCESS Theme Co-Leads

December 11, 2023

in ACCELERATE

ACCELERATE Paediatric Strategy Forum Expression of Interest

The 13th ACCELERATE Paediatric Strategy Forum Expression of Interest is officially open! Join us for this crucial discussion on the Medicinal Product Development of Diffuse Midline Gliomas. This time, we’re honored to be hosted by the Hospital for Sick Children (SickKids) in Toronto for this impactful event.

May 8 & 9, 2024
SickKids, Toronto, Ontario

Learn more and submit an expression of interest!

Deadline for expression of interest: January 22, 2024

December 8, 2023

in C17 Research Network, Funding Opportunities, The 100% Fund

Call for Applications – 100% Fund Grant Competition in Infant Leukemia – deadlines extended!

This call for Infant Leukemia grant applications is part of the larger 100% Fund Grant Competition that is also funding research in rhabdomyosarcoma and osteosarcoma (Round 4).

Nearly one in five children diagnosed with cancer will not survive. For children with rare and hard to treat cancers, the odds can be far worse. The 100% Fund has been created to challenge these odds. Phoebe Rose Rocks Foundation, Fight Like Mason Foundation, Mélia’s Memory, Team Finn, Eli’s Childhood Cancer Foundation, AnnFrances Tropea Foundation, Kindred Foundation and Childhood Cancer Canada have partnered to fund research for children and teens who do not, yet, have their cure.

The 100% Fund targets pediatric and adolescent cancers that are hard to treat – cancers that have not responded to available therapies. The goal is to fund research with the potential to deliver improved treatment and increased survival rates.

C17 is accepting one application addressing Infant Leukemia in consideration of this grant competition.

DEADLINES:
JANUARY 3, 2024: Registration Deadline
JANUARY 24, 2024: Grant Submission Deadline

Download the Call for Applications, 100% Fund Grant Application Form and the C17 Application Instructions and Award Guide from our website.

November 14, 2023

in Job Postings

JOB POSTING – Pediatric Hematology/Oncology, Dalhousie University & IWK Health, Halifax, Nova Scotia

Clinical Faculty Position
Pediatric Hematology/Oncology
Dalhousie University & IWK Health
Halifax, Nova Scotia

The Division of Hematology/Oncology, Department of Pediatrics at Dalhousie University Faculty of Medicine and IWK Health is seeking a full-time (1.0 FTE) physician at the Assistant, Associate or Full Professor level.

The candidate will add to a dynamic and academically highly productive group of 5 collegial pediatric hematologists/oncologists and three nurse practitioners. The primary appointment will be clinical with duties in pediatric hematology and oncology. Candidates with expertise in, and passion for, leukemia, hematological malignancies, including stem cell transplant/cellular therapy, will be given priority. Teaching and research FTE is negotiable based on expertise and interest.

The Division, based within the Department of Pediatrics, is very active in clinical care and clinical research, and has strong representation at a national and international level, and in university and community teaching. The Division has a fully accredited Royal College Pediatric Hematology/Oncology subspecialty Residency Program. IWK Health is a Children’s Oncology Group accredited centre and works in conjunction with an excellent interdisciplinary team, sharing care with community pediatric teams, to serve approximately 55 new oncology and 100 -130 new hematology patients diagnosed each year from across the Maritime Provinces, many with challenging diagnostic and management problems.

Qualifications must include an MD degree (or equivalent) from an accredited university and eligibility for certification in pediatric hematology/oncology or equivalent experience. Eligibility for medical licensure in the Province of Nova Scotia is essential. Compensation and academic appointment is commensurate with experience and qualifications. Cross-appointment to relevant Departments is possible for interested candidates.

IWK Health http://www.iwk.nshealth.ca/ is an academic tertiary care pediatric and maternal care hospital and serves as the pediatric referral centre for the Maritime Provinces. Dalhousie University <http://www.dal.ca/> is located in Halifax <http://www.halifaxinfo.com/>, a cosmopolitan port city and the capital of Nova Scotia <http://www.novascotia.com/>. Halifax is alive with culture and heritage and embraced by the Atlantic Ocean.

Interested applicants must submit a current CV and a statement outlining their academic, teaching and research interests. Applicants must also provide the names and contact information for three referees (two of which must be academic).

Applications will be accepted until December 30, 2023

To apply for this position, please go to http://dal.peopleadmin.ca/

November 8, 2023

in Funding Opportunities, LLSC

LLSC Blood Cancer Quality of Life Grant

Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Blood Cancer Quality of Life Grant Competition.

Quality of life issues for people affected by a blood cancer have been less well studied than other fields of research. The intent of this funding opportunity is to support new research designed to address quality of life challenges experienced by Canadians affected by blood cancers from the time of their diagnosis until entry into end-of-life care. Quality of life cancer research has the potential to make a significant impact on the burden of disease in patients, survivors and caregivers.

The Blood Cancer Quality of Life research grant’s LOI deadline is November 16, 2023.

For more information and to apply, please click HERE